Q2 2017 Pacira Pharmaceuticals Inc Earnings Call

2/8/2017 8:30

Conference Call Pacira Pharmaceuticals Inc

Pacira Pharmaceuticals Inc Conference call or earnings call will be held on Aug 2, 2017 During the earnings conference call's session Pacira Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Pacira Pharmaceuticals Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for our California operating subsidiary of the same name, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or Skyepharma (referred to in this Annual Report on Form 10-K as the "Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal executive offices are located at 5 Sylvan Way, Suite 300, Parsippany, New Jersey 07054, and our telephone number is (973) 254-3560. Pacira®, EXPAREL®, DepoFoam®, DepoCyt® (U.S.    
Read more Conference Call

Pacira Pharmaceuticals Inc (PCRX)

5 Sylvan Way, Parsippany New Jersey 07054, United States